XTL Biopharmaceuticals Ltd. Stock Forecast
A very red day for XTL Biopharmaceuticals Ltd. stock price after a -6.25% fall in the Thursday trading session
(Updated on Apr 25, 2024)
The XTL Biopharmaceuticals Ltd. stock price fell by -6.25% on the last day (Thursday, 25th Apr 2024) from $2.56 to $2.40. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 2.53% from a day low at $2.37 to a day high of $2.43. The price has fallen in 7 of the last 10 days and is down by -13.04% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -27 thousand shares and in total, 6 thousand shares were bought and sold for approximately $14.83 thousand.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.07 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 192.22% during the next 3 months and, with a 90% probability hold a price between $6.05 and $11.72 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
XTLB Signals & Forecast
The XTL Biopharmaceuticals Ltd. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.51. On a fall, the stock will find some support from the long-term average at approximately $2.29. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 03, 2024, and so far it has fallen -27.93%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for XTL Biopharmaceuticals Ltd. stock
XTL Biopharmaceuticals Ltd. finds support from accumulated volume at $2.38 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0600 between high and low, or 2.53%. For the last week the stock has had daily average volatility of 6.25%.
XTL Biopharmaceuticals Ltd. is oversold on RSI14 (21). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: $2.24 (-6.58%) (This stock has high daily movements and this gives high risk. Low RSI14 is 21 which reduces the risk some. There is a sell signal from a pivot top found 16 days ago.)
Trading Expectations (XTLB) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect XTL Biopharmaceuticals Ltd. to open at $2.40, and during the day (based on 14 day Average True Range), to move between $2.12 and $2.68, which gives a possible trading interval of +/-$0.279 (+/-11.63%) up or down from last closing price. If XTL Biopharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 23.25% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.42 (0.83%) than the support at $2.38 (0.83%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is XTL Biopharmaceuticals Ltd. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for XTL Biopharmaceuticals Ltd. stock to perform well in the short-term.
Current score: 2.659 Buy Candidate Unchanged
Predicted Opening Price for XTL Biopharmaceuticals Ltd. of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $2.40 ( 0.00000000%) | $2.40 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for XTLB
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.46 | 2.50 % | |
| R2 | 2.44 | 1.55 % | ||
| R1 | 2.42 | 0.96 % | ||
| Current price: | 2.40 | |||
| Support | S1 | 2.38 | -0.95 % | |
| S2 | 2.36 | -1.54 % | ||
| S3 | 2.34 | -2.50 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.81 | 17.08 % | |
| R2 | 2.62 | 9.17 % | ||
| R1 | 2.42 | 0.83 % | ||
| Current price | 2.40 | |||
| Support | S1 | 2.38 | -0.83% | |
| S2 | 0 | . | ||
| S3 | 0 | . |
FAQ
Click here for our free guide on how to buy XTL Biopharmaceuticals Ltd. Stock.
